PPTA Twitter

PlasmaProteins For individuals with #rarediseases --like primary immunodeficiency--timely diagnosis, access to specialists and #plasmaprotein therapies are life-saving. #ShowYourStripes bit.ly/2JFf1Db pic.twitter.com/fvO1nfG10q
1 day ago.
PlasmaProteins For Sam, access to #plasmaprotein therapies allows him to do more of what he loves, like playing in the school band. Read Sam's story: bit.ly/2yRIPJn pic.twitter.com/pECj0zihtw
3 days ago.

IQPP Standards Public Review Period Now Open!

The following draft has been issued for public review:

Public Review Draft 1, Proposed Revision to Version 4.0 of the IQPP Quality Assurance Standard

In accordance with the procedures for developing PPTA Voluntary Standards, the public comment period will be open for sixty days, until April 20, 2019. This is a proposed revision of the current version of the standard. After the close of the comment period, all comments received in relation to the drafts will be considered. If resolution to the comments received results in substantive changes to a draft, another comment period may be initiated for that draft. If resolution to the comments results in no or minor changes to a draft, the draft may be implemented as part of the IQPP Voluntary Standards Program. Adequate notice will be provided prior to the implementation period of any PPTA standard or specification.

All comments must be sent to Sonia Balboni at sbalboni@pptaglobal.org by April 20, 2019.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100